Rubin Joseph 5
5 · Cytosorbents Corp · Filed Feb 14, 2013
Insider Transaction Report
Form 5
Rubin Joseph
Director
Transactions
- Conversion
Series B Convertible Preferred
2009-10-05$3620.00/sh+36.2$131,044→ 203.54 totalExercise: $0.04→ Common Stock, par value $0.001 per share (100,000 underlying)
Footnotes (3)
- [F1]Immediately exercisable
- [F2]Not Applicable
- [F3]This amount includes all shares of Series B Convertible Preferred stock issued as quarterly dividend shares. The Series B Convertible Preferred Stock pays dividends quarterly at a rate of 10% per annum. If fully converted, they would be convertible into 562,265 shares of Common Stock